Intracardiac Leiomyoma Leading to Liver Failure and Heart Failure Managed by VA-ECMO and Surgical Resection

Tsz Ho Chan1, Kin Ho Wong1, Chi Wing Wong1

  • 1Division of Cardiology, Department of Medicine and Geriatrics, Pok Oi Hospital, Yuen Long, Hong Kong.

JACC. Case Reports
|July 25, 2025
PubMed

Insights

Intracardiac leiomyomatosis (ICL) is a rare tumor causing heart failure. Early diagnosis and extracorporeal membrane oxygenation (ECMO) support are vital for surgical treatment and improved outcomes.

Area of Science:

  • Cardiology
  • Oncology
  • Pathology

Background:

  • Intracardiac leiomyomatosis (ICL) is a rare condition involving intracardiac tumors, often linked to uterine leiomyomas.
  • Early diagnosis of ICL is critical due to the potential for severe cardiac complications.

Observation:

  • A 52-year-old woman presented with liver and heart failure attributed to a large right ventricular leiomyoma.
  • The patient required venoarterial extracorporeal membrane oxygenation (ECMO) for stabilization.
  • Surgical resection of the tumor was performed, with histological confirmation of a benign smooth muscle tumor.

Findings:

  • ICL can present with multiorgan failure, posing diagnostic and management challenges.
  • ECMO proved effective as a bridge therapy to surgical intervention.
  • Benign smooth muscle tumors can manifest as intracardiac masses.

Implications:

  • ICL must be considered in patients with right-sided intracardiac masses, particularly those with a history of hysterectomy.
  • Aggressive management, including ECMO and timely surgery, is essential for improving outcomes in ICL patients.
  • This case underscores the importance of a high index of suspicion for rare cardiac tumors in complex clinical presentations.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
23
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
33
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
144
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52